KRAS and neoplasm: As listed in Table 1, the expression of HMMR in CRC tissues was not associated with the patients’ age, sex, TNM stage, clinical stage, tumor location, and KRAS mutation status (p > 0.05), indicating that the expression of HMMR in CRC tissues was independent of these clinical parameters.